[Social problems of porphyria]

Area of Science:

• Medical Science
• Neurology
• Pharmacology

Background:

• Acute porphyrias are rare metabolic disorders with potential long-term health consequences.
• Understanding the late effects of porphyria is crucial for patient management and support.

Purpose of the Study:

• To investigate the late consequences of acute porphyria attacks.
• To assess the prevalence of disability and employment challenges in porphyria patients.
• To evaluate medication use and the risk of drug dependence in patients with porphyria.

Main Methods:

• Retrospective study of 312 patients with a history of acute porphyria attacks.
• Assessment of neurological and psychological sequelae.
• Analysis of disability pension status and employment changes in a subgroup of 200 patients in remission.
• Review of medication use, specifically Dolargan (Pethidine).

Main Results:

• Neuropathy was observed in 9 patients (2.9%) and psychoneurological changes in 1 patient (0.3%).
• Among 200 patients in remission, 72 (36%) received a disability pension.
• Patients experienced difficulties changing professions due to health reasons.
• Dolargan (Pethidine) was frequently prescribed to patients in remission, indicating a high risk for developing drug dependence.

Conclusions:

• Acute porphyria can lead to significant long-term motor disability and psychoneurological issues.
• A substantial percentage of porphyria patients require disability pensions and face vocational challenges.
• The frequent use of Pethidine in remission poses a considerable risk of drug dependence in porphyria patients.